Kite Pharma logo

Kite Pharma

Venture Capital

Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer.

Founded 2009 United States Santa Monica, United States 1-10 employees Biotechnology, Health Care +1

12

Total Investments

10

Portfolio Companies

-

Exits

3

Industries

General Information

Industries Biotechnology, Health Care +1

Company Overview

Founded 2009
Employees 1-10
Location United States Santa Monica, United States
Website kitepharma.com

Investment Criteria

Investment Thesis

•••••• •••••• ••••••

About Kite Pharma

Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development. For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago. With an unrelenting drive and a singular focus on cell therapy, our team is executing on our strategy to bring life-saving therapies to patients. In all areas of the company, we are looking for the very best people who share our deep passion to cure cancer. We realize that our ambitious goals can only be achieved if every employee is fully committed to our mission and embraces our entrepreneurial spirit. If this describes you, please contact us. Our corporate headquarters are in Santa Monica, California.

Recent Investments (12)

View All
Company Stage Amount Date
Series C •••••• Nov 2025
Acquisition •••••• Aug 2025
Post Ipo Equity •••••• Nov 2023
Series B •••••• May 2023
Post Ipo Equity •••••• Dec 2022
Portfolio company •••• ••••
Acquisition •••••• Dec 2022
Portfolio company •••• ••••
Post-IPO Equity •••••• Jul 2022
Portfolio company •••• ••••
Late Vc •••••• Nov 2021
Portfolio company •••• ••••
Early VC •••••• Apr 2021
Portfolio company •••• ••••
Series C •••••• Feb 2020

See all 12 investments →

All startup & investor data, one platform.

Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.

Access Millions of Companies and 50K+ Investors

Signal-based outbound intelligence for sales, agencies, and investors.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes